Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3682058013 | Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3682059017 | Product containing precisely pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Is a | Product containing pioglitazone (medicinal product) | false | Inferred relationship | Some | ||
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Has active ingredient | Thiazolidinedione (substance) | false | Inferred relationship | Some | ||
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Has active ingredient | Oral hypoglycemic | false | Inferred relationship | Some | ||
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Has active ingredient | Pioglitazone (substance) | false | Inferred relationship | Some | ||
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Has active ingredient | Pioglitazone hydrochloride | false | Inferred relationship | Some | ||
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Has active ingredient | Pioglitazone hydrochloride | false | Inferred relationship | Some | 1 | |
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Has basis of strength substance (attribute) | Pioglitazone (substance) | true | Inferred relationship | Some | 1 | |
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Has presentation strength numerator value | 30 | false | Inferred relationship | Some | 1 | |
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Has precise active ingredient | Pioglitazone hydrochloride | true | Inferred relationship | Some | 1 | |
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Is a | Product containing pioglitazone in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet | Is a | Product containing only pioglitazone in oral dose form (medicinal product form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR